Monograph Details
|
|
Hematology
> Thromboembolic disorders
|
|
FASPRIN |
| Manufacturer |
|
Improvita Health Products |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Antiplatelet. |
| Generic Name |
|
Aspirin 81mg; orally-disintegrating tabs; citrus burst flavor. |
| Indications |
|
To reduce the risk of stroke and MI. |
| Children |
Not recommended.
|
| Adults |
|
Dissolve on tongue. 1 tab daily. Emergency treatment: 2 tabs at first sign of MI or stroke. |
| Contraindications |
|
NSAID allergy. Viral infection in children and teenagers. |
| Precautions |
|
History of asthma or peptic ulcer. Severe hepatic or renal dysfunction. Bleeding disorders. Diabetes. Gout. Arthritis. Pregnancy (avoid during 3rd trimester), nursing mothers: not recommended. |
| Interactions |
|
Potentiates anticoagulants, hypoglycemics, methotrexate, acetazolamide, valproic acid, highly protein-bound drugs. Urinary alkalinizers, antacids, corticosteroids may increase excretion. May antagonize ACE inhibitors, β-blockers, diuretics, uricosurics. Increased bleeding risk with NSAIDs or chronic, heavy alcohol use. NSAIDs increase risk of renal dysfunction. |
| Adverse Reactions |
|
GI upset/bleed, prolonged bleeding time, anaphylaxis, salicylism. |
| How Supplied |
|
Orally-disintegrating tabs—30 |
|
|
|
|
